Inject once daily, subcutaneously, rotating between the abdomen, thighs, and upper arms
You will get support from health professionals all through your journey
Gaudncio FN et al
Tailored to individual needs, this treatment optimizes liver function, improves energy levels, and enhances overall health and well-being
The correct classification: Pure GLP-1 agonists: exenatide, liraglutide, lixisenatide, dulaglutide, semaglutide, efpeglenatide, orforglipron Dual GIP/GLP-1 agonists: tirzepatide Triple agonists (GIP/GLP-1/glucagon): retatrutide Retatrutide, approved in early 2026, adds glucagon receptor agonism to the dual GIP/GLP-1 mechanism
Per serving (15ml)